| 标题 |
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Yelena Y. Janjigian; Kohei Shitara; Markus Moehler; Marcelo Garrido; Pamela Salman; et al 出版日期:2021-06-05 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)